NASDAQ:CPXX (CPXX) (CPXX) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free CPXX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$30.24▼$30.2450-Day Range N/A52-Week Range$1.12▼$30.36VolumeN/AAverage Volume2.62 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About (CPXX) Stock (NASDAQ:CPXX)Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.Read More Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CPXX Stock News HeadlinesMay 6, 2024 | msn.comJuan Soto-Cardinals connection is a pipe dream for St. LouisJune 21, 2023 | msn.comUkraine Inches Towards Russian Stronghold as Counteroffensive Pushes OnJune 21, 2023 | msn.comSundowns take long term view on Olwethu MakhanyaJune 21, 2023 | msn.com13 of The Dumbest Childhood Trends We Can't Believe We DidJune 11, 2023 | msn.comRoughriders edge Elks 17-13 in season-opening road winJune 11, 2023 | msn.comUK to be hit with a month's worth of rain but will still be hotter than MonacoMarch 29, 2023 | msn.comLawmakers tour State Police Academy in New Braintree, tout recruitment fundingMarch 14, 2023 | msn.comLittle Bear's Big Trip - TrailerMarch 14, 2023 | msn.comSon Accused Of Fatally Stabbing His Parents In South Jersey: ProsecutorMarch 7, 2023 | afr.comMacquarie Capital injects $150m into PE-owned IT services playerFebruary 7, 2023 | msn.comMasood calls for diplomacy to resolve Kashmir issueJanuary 22, 2023 | msn.comLeeds vs Brentford result: latest updates and live reaction to Premier League matchJanuary 22, 2023 | msn.comLeeds vs Brentford, Premier League live: Score and latest updatesDecember 12, 2022 | msn.comWhy The GMC Canyon Will Be Much More Expensive In 2023December 12, 2022 | msn.comMissouri Lottery player wins $50K after stop for gas in Kansas CitySeptember 25, 2022 | msn.comThe new youth-led Cardiff café that’s ‘better than Starbucks’September 8, 2022 | msn.comWhy There's So Much Confusion Surrounding Archie And Lilibet's New TitlesAugust 29, 2022 | msn.comNicki Minaj Performs for a Room Filled with BarbzAugust 23, 2022 | theglobeandmail.comBiggest stock winners from mammoth new U.S. spending bill. Plus, what a $4-billion dividend fund manager is buying and sellingSee More Headlines Company Calendar Last Earnings5/10/2016Today5/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CPXX CUSIPN/A CIK1327467 WebN/A Phone+1-609-2430123FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A CPXX Stock Analysis - Frequently Asked Questions How were (CPXX)'s earnings last quarter? (CPXX) (NASDAQ:CPXX) released its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.01. What other stocks do shareholders of (CPXX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CPXX) investors own include Consolidated Water (CWCO), Anavex Life Sciences (AVXL), Alder Biopharmaceuticals (ALDR), SharkNinja (SN), Fc Global Realty (FCRE), Chipotle Mexican Grill (CMG), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA) and VASCO Data Security International (VDSI). This page (NASDAQ:CPXX) was last updated on 5/26/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBill Gates is all about this tiny $2 stockTimothy SykesNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist My Default Watchlist Adding (CPXX) You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.